Your browser doesn't support javascript.
loading
Cytomegalovirus DNAemia in haematological patients undergoing CD19-directed chimeric antigen receptor T-cell therapy: should it be systematically monitored?
Solano de la Asunción, Carlos; Hernani, Rafael; Albert, Eliseo; Gómez, María Dolores; Giménez, Estela; Benzaquén, Ana; González-Barberá, Eva María; Hernández-Boluda, Juan Carlos; Pérez, Ariadna; Piñana, José Luis; Chorao, Pedro; Guerreiro, Manuel; Montoro, Juan; Sanz, Jaime; Solano, Carlos; Navarro, David.
Affiliation
  • Solano de la Asunción C; Microbiology Service, Hospital Clínico Universitario, Institto De Investigación Sanitaria (INCLIVA Health Research Institute), Valencia, Spain.
  • Hernani R; Hematology Service, Hospital Clínico Universitario, Institto De Investigación Sanitaria (INCLIVA Health Research Institute), Valencia, Spain.
  • Albert E; Microbiology Service, Hospital Clínico Universitario, Institto De Investigación Sanitaria (INCLIVA Health Research Institute), Valencia, Spain.
  • Gómez MD; Microbiology Service, Hospital Universitario y Politécnico "La Fe", Valencia, Spain.
  • Giménez E; Microbiology Service, Hospital Clínico Universitario, Institto De Investigación Sanitaria (INCLIVA Health Research Institute), Valencia, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
  • Benzaquén A; Hematology Service, Hospital Clínico Universitario, Institto De Investigación Sanitaria (INCLIVA Health Research Institute), Valencia, Spain.
  • González-Barberá EM; Microbiology Service, Hospital Universitario y Politécnico "La Fe", Valencia, Spain.
  • Hernández-Boluda JC; Hematology Service, Hospital Clínico Universitario, Institto De Investigación Sanitaria (INCLIVA Health Research Institute), Valencia, Spain; Department of Medicine, School of Medicine, University of Valencia, Valencia, Spain.
  • Pérez A; Hematology Service, Hospital Clínico Universitario, Institto De Investigación Sanitaria (INCLIVA Health Research Institute), Valencia, Spain.
  • Piñana JL; Hematology Service, Hospital Clínico Universitario, Institto De Investigación Sanitaria (INCLIVA Health Research Institute), Valencia, Spain.
  • Chorao P; Hematology Service, Hospital Universitario y Politécnico "La Fe", Valencia, Spain.
  • Guerreiro M; Hematology Service, Hospital Universitario y Politécnico "La Fe", Valencia, Spain.
  • Montoro J; Hematology Service, Hospital Universitario y Politécnico "La Fe", Valencia, Spain.
  • Sanz J; Hematology Service, Hospital Universitario y Politécnico "La Fe", Valencia, Spain.
  • Solano C; Hematology Service, Hospital Clínico Universitario, Institto De Investigación Sanitaria (INCLIVA Health Research Institute), Valencia, Spain; Department of Medicine, School of Medicine, University of Valencia, Valencia, Spain.
  • Navarro D; Microbiology Service, Hospital Clínico Universitario, Institto De Investigación Sanitaria (INCLIVA Health Research Institute), Valencia, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain; Department of Microbiology, School of Me
Clin Microbiol Infect ; 29(8): 1093-1095, 2023 08.
Article in En | MEDLINE | ID: mdl-37182642

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cytomegalovirus Infections / Receptors, Chimeric Antigen Limits: Humans Language: En Journal: Clin Microbiol Infect Journal subject: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Year: 2023 Document type: Article Affiliation country: Spain Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cytomegalovirus Infections / Receptors, Chimeric Antigen Limits: Humans Language: En Journal: Clin Microbiol Infect Journal subject: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Year: 2023 Document type: Article Affiliation country: Spain Country of publication: United kingdom